NEW YORK (GenomeWeb News) – The National Institute of Arthritis and Musculoskeletal and Skin Diseases seeks to support small businesses that are developing potential biomarker platforms to predict the onset and progression of inflammatory diseases, the institute said yesterday.

Under the Small Business Innovation Research Fast Track grant program, NIAMS plans to award up to $450,000 in 2014 for two Phase I projects, and it later may provide up to $1.5 million in total costs for each of the projects.